IP Library Granted Patent US 8,818,514
Granted Patent B2
US 8,818,514 · App. 13/934,133 · Granted Aug 26, 2014

Methods for intravascularly-induced neuromodulation

Inventors: Denise Zarins (Saratoga, CA); Nicolas Zadno (Fremont, CA); Benjamin J. Clark (Redwood City, CA); Erik Thai (Mountain View, CA)
Assignee: Medtronic Ardian Luxembourg S.a.r.l.
A61B18/1492A61N1/36182A61N1/37205A61N1/36121A61N1/36007A61N1/40A61N1/327A61M25/0108A61M25/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,818,514
App. No.
13/934,133
Granted
Aug 26, 2014
Kind
B2
Abstract

Methods for intravascularly-induced renal neuromodulation. In some embodiments, a method can include positioning a pair of bipolar electrodes within renal vasculature of a human patient and expanding a balloon within the renal vasculature. The method can further include delivering an electric field via the bipolar electrodes.

Claims (38)

1. A method for intravascularly-induced renal neuromodulation, the method comprising:

intravascularly positioning a catheter comprising a balloon and a pair of bipolar electrodes within renal vasculature of a human patient;

expanding the balloon within the renal vasculature; and

delivering an electric field via the bipolar electrodes to induce renal neuromodulation,

wherein inducing renal neuromodulation results in a therapeutically beneficial reduction in blood pressure of the patient.

2. The method of claim 1 wherein intravascularly positioning a catheter within renal vasculature of a human patient comprises positioning the catheter within a renal artery of the patient.

3. The method of claim 1 wherein intravascularly positioning a catheter within renal vasculature of a human patient comprises intravascularly delivering the catheter to the renal vasculature over a guidewire.

4. The method of claim 1 wherein intravascularly positioning a catheter within renal vasculature of a human patient comprises intravascularly delivering the catheter to the renal vasculature within a guide catheter.

5. The method of claim 1 wherein expanding the balloon within the renal vasculature further comprises occluding blood flow in the renal vasculature with the balloon.

6. The method of claim 1 wherein expanding the balloon within the renal vasculature further comprises locally increasing impedance within the renal vasculature via the balloon.

7. The method of claim 6 wherein locally increasing impedance further comprises directing the electric field across a wall of the renal vasculature between the bipolar electrodes.

8. The method of claim 1 wherein the pair of bipolar electrodes are carried by a shaft of the catheter.

9. The method of claim 1 wherein the bipolar pair of electrodes comprises a first pair of bipolar electrodes arranged about the balloon, and wherein the catheter further comprises a second pair of bipolar electrodes arranged thereabout.

10. The method of claim 1 wherein delivering an electric field via the bipolar electrodes to induce renal neuromodulation comprises thermally inhibiting neural communication along neural fibers innervating a kidney of the patient.

11. The method of claim 1 wherein delivering an electric field via the bipolar electrodes to induce renal neuromodulation comprises ablating neural fibers innervating a kidney of the patient via the electric field.

12. The method of claim 1 wherein delivering an electric field via the bipolar electrodes to induce renal neuromodulation comprises partially ablating neural fibers innervating a kidney of the patient via the electric field.

13. The method of claim 1 wherein delivering an electric field via the bipolar electrodes to induce renal neuromodulation comprises at least partially denervating a kidney of the patient.

14. The method of claim 1 , further comprising removing the catheter from the patient after therapy.

15. The method of claim 1 , further comprising monitoring a parameter of target tissue and/or non-target tissue within the patient before and during energy delivery.

16. The method of claim 15 wherein monitoring a parameter comprises monitoring temperature of target tissue, and wherein the method further comprises maintaining the target tissue at a desired temperature during energy delivery.

17. The method of claim 15 , further comprising altering energy delivery in response to the monitored parameter.

18. A method for catheter-based renal denervation of a human patient, the method comprising:

transluminally positioning a renal denervation catheter within a renal artery of the patient and adjacent to neural fibers that innervate a kidney of the patient, wherein the catheter includes a balloon and a pair of bipolar electrodes;

inflating the balloon within the renal artery of the patient; and

after inflating the balloon, at least partially ablating the neural fibers of the patient via energy from the bipolar electrodes,

wherein at least partially ablating the neural fibers results in a therapeutically beneficial reduction in central sympathetic overactive of the patient.

19. The method of claim 18 wherein at least partially ablating the neural fibers results in a therapeutically beneficial reduction in blood pressure in the patient.

20. The method of claim 18 , further comprising monitoring temperature of target tissue within the patient before and during energy delivery, and wherein the method further comprises altering energy delivery to the neural fibers via the bipolar electrodes throughout therapy to maintain the target tissue at a predetermined temperature.

21. A method for treating a human patient diagnosed with hypertension, the method comprising:

positioning a catheter comprising a balloon and a pair of electrode poles within renal vasculature of the patient;

expanding the balloon within the renal vasculature; and

thermally inhibiting neural communication along neural fibers that innervate a kidney of the patient via an electric field from the electrode poles,

wherein inhibiting the neural communication results in a therapeutically beneficial reduction in blood pressure of the patient.

22. The method of claim 21 wherein positioning a catheter comprising a balloon and a pair of electrode poles within renal vasculature of the patient comprises positioning the catheter within a renal artery of a patient.

23. The method of claim 21 wherein positioning a catheter comprising a balloon and a pair of electrode poles within renal vasculature of the patient comprises intravascularly delivering the catheter to the renal vasculature within a guide catheter.

24. The method of claim 21 wherein expanding the balloon within the renal vasculature comprises occluding blood flow in the renal vasculature with the balloon.

25. The method of claim 21 wherein thermally inhibiting neural communication along neural fibers that innervate a kidney of the patient via an electric field from the electrode poles comprises ablating the neural fibers.

26. The method of claim 21 , further comprising removing the catheter from the patient after thermally inhibiting neural communication along neural fibers that innervate the kidney of the patient via the electric field from the electrode poles.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 22, 2014
From: DEMARAIS, DENISE; ZADNO, NICOLAS; CLARK, BENJAMIN J.; THAI, ERIK
To: ARDIAN, INC.
Reel/Frame 032021/0683 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 22, 2014
From: MEDTRONIC ARDIAN LLC
To: MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L.
Reel/Frame 032021/0803 →
CHANGE OF NAME Recorded Jan 22, 2014
From: ARDIAN, INC.
To: MEDTRONIC ARDIAN LLC
Reel/Frame 032113/0591 →
Continuity (11)
Continuation 12827700 · Jun 30, 2010
Division 11266993 · Nov 4, 2005
Continuation In Part 11129765 · May 13, 2005
Continuation In Part 10408665 · Apr 8, 2003
Continuation In Part 11189563 · Jul 25, 2005
Provisional Application 60616254 · Oct 5, 2004
Provisional Application 60624793 · Nov 2, 2004
Provisional Application 60442970 · Jan 29, 2003
Provisional Application 60415575 · Oct 3, 2002
Provisional Application 60370190 · Apr 8, 2002
Related Publication 20140012258A1 · Jan 9, 2014